We are live on ! Find out more
AC

Amitell Capital Portfolio holdings

AUM $62.4M
1-Year Est. Return 75.98%
This Fund
S&P 500
This Quarter Est. Return
+6.85%
1 Year Est. Return
+75.98%
3 Year Est. Return
+179.75%
5 Year Est. Return
+391.38%
10 Year Est. Return
–
AUM
$50.1M
AUM Growth
+$6.19M
Cap. Flow
+$5.95M
Cap. Flow %
11.87%
Top 10 Hldgs %
71.31%
Holding
30
New
11
Increased
3
Reduced
–
Closed
7

Top Buys

Rank Stock Value
1
NEM icon
Newmont
NEM
+$2.76M
2
B
Barrick Mining
B
+$2.67M
3
AEM icon
Agnico Eagle Mines
AEM
+$2.65M
4
AGI icon
Alamos Gold
AGI
+$2.53M
5
CHRD icon
Chord Energy
CHRD
+$2.46M

Top Sells

Rank Stock Value
1
OBIO icon
Orchestra BioMed
OBIO
+$5.98M
2
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$4.63M
3
FIS icon
Fidelity National Information Services
FIS
+$3.37M
4
INSW icon
International Seaways
INSW
+$2.41M
5
RCKT icon
Rocket Pharmaceuticals
RCKT
+$1.34M

Sector Composition

Rank Sector Weight
1 Materials 29.65%
2 Consumer Discretionary 15.95%
3 Financials 15.19%
4 Energy 12.13%
5 Healthcare 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OBIO icon
26
Orchestra BioMed
OBIO
$231M
– –
-600,139
Closed -$5.98M
PTGX icon
27
Protagonist Therapeutics
PTGX
$8.69B
– –
-50,129
Closed -$397K
RCKT icon
28
Rocket Pharmaceuticals
RCKT
$351M
– –
-97,331
Closed -$1.34M
STOK icon
29
Stoke Therapeutics
STOK
$1.8B
– –
-64,807
Closed -$856K
XLE icon
30
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
– –
-129,490
Closed -$4.63M
1
2

Similar funds

BGPJL
Bregal General Partner Jersey Ltd St. Helier, Jersey $62.3M AUM
KA
KDT Advisors New York $62.8M AUM 25.12% 1-Year Est. Return
1I
1888 Investments Denver, Colorado $63M AUM 26.65% 1-Year Est. Return
AIM
Avanda Investment Management Singapore $63.1M AUM 2.43% 1-Year Est. Return
CSTB
Charles Schwab Trust Bank Henderson, Nevada $63.3M AUM 9.73% 1-Year Est. Return
HPCM
Hein Park Capital Management New York $61.3M AUM 14.47% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
HFCIV
H&F Corporate Investors VIII San Francisco, California $63.5M AUM 20.79% 1-Year Est. Return

Amitell Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Amitell Capital held 30 positions worth $50.1M, up 14% from $43.9M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Amitell Capital deployed $5.95M of net new capital in Q3 2022, opening 11 new positions and adding to 3 existing holdings. Its largest new stake was Newmont: 59,160 shares worth $2.49M.

By sector, the portfolio is most concentrated in Materials at 30% of assets, up from 6.7% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the most notable exit was Orchestra BioMed, an estimated $5.98M sold.

  • Amitell Capital's largest Q3 2022 buy was Newmont: 59,160 shares worth $2.49M.
  • Amitell Capital added most to First Citizens BancShares in Q3 2022, an estimated $1.83M increase.
  • Amitell Capital fully exited Orchestra BioMed in Q3 2022, selling an estimated $5.98M.
  • Amitell Capital's ten largest holdings make up 71% of its $50.1M portfolio in Q3 2022.
  • Amitell Capital opened 11 new positions and closed 7 in Q3 2022.
  • Amitell Capital's portfolio value rose 14% quarter-over-quarter to $50.1M.

Based on Amitell Capital's 13F filing for Q3 2022, filed 10 Nov 2022.